Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-10

Clinical Trial Update: Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction [NA]

View source ↗

Summary

A completed clinical trial evaluating weight loss as a therapeutic approach for heart failure with preserved ejection fraction (HFpEF).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of South Carolina | Conditions: Heart Failure, Diastolic, Weight Loss | NA | Status: COMPLETED